Research and Markets: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012 Reviews Key Players Involved In the Therapeutic Development
Research and Markets (http://www.researchandmarkets.com/research/ltbd3f/bcell) has announced the addition of Global Markets Direct's new report "B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012" to their offering.
Global Markets Direct's, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, Global Markets Direct's, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for B-Cell Non-Hodgkin Lymphoma. B-Cell Non-Hodgkin Lymphoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the B-Cell Non-Hodgkin Lymphoma pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
- Bristol-Myers Squibb Company
- Johnson & Johnson
- Kyowa Hakko Kirin Co., Ltd.
- Genentech, Inc.
- MedImmune LLC
- Gilead Sciences, Inc.
- Reliance Life Sciences Pvt. Ltd.
- Millennium Pharmaceuticals, Inc.
- Astellas Pharma Inc.
- Biocon Limited
- Cephalon, Inc.
- SuperGen, Inc.
- Merck KGaA
- Celldex Therapeutics, Inc.
- IMMUNOMEDICS, INC
- Allos Therapeutics, Inc
- Portola Pharmaceuticals, Inc.
- Provenance Biopharmaceuticals Corp.
- Synthon Pharmaceuticals, Inc.
- Astellas Pharma GmbH
- LFB Biotechnologies, S.A.S.U.
For more information visit http://www.researchandmarkets.com/research/ltbd3f/bcell
Source: Global Markets Direct